These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10670879)

  • 21. Laparoscopic radiofrequency ablation of unresectable hepatic malignancies. A phase 2 trial.
    Chung MH; Wood TF; Tsioulias GJ; Rose DM; Bilchik AJ
    Surg Endosc; 2001 Sep; 15(9):1020-6. PubMed ID: 11443478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency ablation of primary and metastatic malignant liver tumors.
    Izzo F; Barnett CC; Curley SA
    Adv Surg; 2001; 35():225-50. PubMed ID: 11579813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of radiofrequency ablation of 343 patients with hepatic tumor and the relevant complications].
    Chen MH; Yan K; Yang W; Gao W; Dai Y; Wang YB; Zhang H; Huo L; Xing BC; Huang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):292-6. PubMed ID: 15968323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients.
    Pawlik TM; Izzo F; Cohen DS; Morris JS; Curley SA
    Ann Surg Oncol; 2003 Nov; 10(9):1059-69. PubMed ID: 14597445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation for unresectable hepatic tumors.
    Wong SL; Edwards MJ; Chao C; Simpson D; McMasters KM
    Am J Surg; 2001 Dec; 182(6):552-7. PubMed ID: 11839316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical short-term results of radiofrequency ablation in liver cancers.
    Jiang HC; Liu LX; Piao DX; Xu J; Zheng M; Zhu AL; Qi SY; Zhang WH; Wu LF
    World J Gastroenterol; 2002 Aug; 8(4):624-30. PubMed ID: 12174368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation.
    Chapman WC; Debelak JP; Wright Pinson C; Washington MK; Atkinson JB; Venkatakrishnan A; Blackwell TS; Christman JW
    Ann Surg; 2000 May; 231(5):752-61. PubMed ID: 10767797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanded treatment of hepatic tumors with radiofrequency ablation and cryoablation.
    Weber SM; Lee FT
    Oncology (Williston Park); 2005 Oct; 19(11 Suppl 4):27-32. PubMed ID: 16366376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency-ablation of unresectable primary and secondary liver tumors: results in 88 patients.
    Hildebrand P; Kleemann M; Roblick UJ; Mirow L; Birth M; Leibecke T; Bruch HP
    Langenbecks Arch Surg; 2006 Apr; 391(2):118-23. PubMed ID: 16604376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned.
    Bleicher RJ; Allegra DP; Nora DT; Wood TF; Foshag LJ; Bilchik AJ
    Ann Surg Oncol; 2003; 10(1):52-8. PubMed ID: 12513961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Realistic expectations for cryoablation of liver tumors.
    Helling TS
    J Hepatobiliary Pancreat Surg; 2000; 7(5):510-5. PubMed ID: 11180879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned.
    Choy PY; Koea J; McCall J; Holden A; Osbourne M
    N Z Med J; 2002 Aug; 115(1159):U128. PubMed ID: 12362172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies.
    Adam R; Hagopian EJ; Linhares M; Krissat J; Savier E; Azoulay D; Kunstlinger F; Castaing D; Bismuth H
    Arch Surg; 2002 Dec; 137(12):1332-9; discussion 1340. PubMed ID: 12470093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with more than 500 minimally invasive hepatic procedures.
    Buell JF; Thomas MT; Rudich S; Marvin M; Nagubandi R; Ravindra KV; Brock G; McMasters KM
    Ann Surg; 2008 Sep; 248(3):475-86. PubMed ID: 18791368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients.
    Curley SA; Marra P; Beaty K; Ellis LM; Vauthey JN; Abdalla EK; Scaife C; Raut C; Wolff R; Choi H; Loyer E; Vallone P; Fiore F; Scordino F; De Rosa V; Orlando R; Pignata S; Daniele B; Izzo F
    Ann Surg; 2004 Apr; 239(4):450-8. PubMed ID: 15024305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation: a minimally invasive technique with multiple applications.
    Bilchik AJ; Rose DM; Allegra DP; Bostick PJ; Hsueh E; Morton DL
    Cancer J Sci Am; 1999; 5(6):356-61. PubMed ID: 10606477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency ablation of unresectable hepatic tumors.
    Geyik S; Akhan O; Abbasoğlu O; Akinci D; Ozkan OS; Hamaloğlu E; Ozmen M
    Diagn Interv Radiol; 2006 Dec; 12(4):195-200. PubMed ID: 17160805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.